How to solve a key bottle neck in the drug discovery process




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: How to solve a key bottle neck in the drug discovery process
Released on: August 03, 2015. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In December 2014 Domainex and ZoBio joined forces to deliver crucial drug target information to support FORMA Therapeutics’ Drug Discovery Programs.
  • Summary
  • Transcript
  • Participants
  • Company
In December 2014 Domainex and ZoBio joined forces to deliver crucial drug target information to support FORMA Therapeutics’ Drug Discovery Programs. PharmaVentures' Adrian Dawkes caught up with Eddy Littler, CEO, Domainex to find out more about this collaboration and how it fits into the Domainex hybrid business model.
In December 2014 Domainex and ZoBio joined forces to deliver crucial drug target information to support FORMA Therapeutics’ Drug Discovery Programs. PharmaVentures' Adrian Dawkes caught up with Eddy Littler, CEO, Domainex to find out more about this collaboration and how it fits into the Domainex hybrid business model.
Eddy Littler
Domainex
Domainex Ltd
Domainex Ltd is a contract research company that was established in 2001 and operates from Cambridge UK. In May 2007 Domainex merged with NCE Discovery to form a new integrated company with capabilities in biology and chemistry.